Similar articles

• Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS.

  Archange YR, Carrey Z, Zanlungo PG. Archange YR, et al. J Int Assoc Physicians AIDS Care. 1995 Aug;1(7):20-2. J Int Assoc Physicians AIDS Care. 1995. PMID: 11362747 Clinical Trial.
• A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.

  Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC. Pierce M, et al. N Engl J Med. 1996 Aug 8;335(6):384-91. doi: 10.1056/NEJM199608083350603. N Engl J Med. 1996. PMID: 8663871 Clinical Trial.
• Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis.

  Bui KQ, McNabb J, Li C, Nightingale CH, Nicolau DP. Bui KQ, et al. Antimicrob Agents Chemother. 1999 Sep;43(9):2302-4. doi: 10.1128/AAC.43.9.2302. Antimicrob Agents Chemother. 1999. PMID: 10471584 Free PMC article. Clinical Trial.
• [Azithromycin and Mycobacterium avium infection].

  Perronne C. Perronne C. Pathol Biol (Paris). 1995 Jun;43(6):565-7. Pathol Biol (Paris). 1995. PMID: 8539084 Review. French.
• Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.

  Cohn DL. Cohn DL. Drugs. 1997;54 Suppl 2:8-15; discussion 28-9. doi: 10.2165/00003495-199700542-00004. Drugs. 1997. PMID: 9358195 Review.